Tags

Type your tag names separated by a space and hit enter

[Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
Zhonghua Liu Xing Bing Xue Za Zhi. 1998 Apr; 19(2):93-6.ZL

Abstract

The changes of annual incidence rates were predicted for 7 cohorts of different ages either with or without vaccination. Cost-effectiveness ratio (CER) was estimated by the annual differences of HA incidence of the two scenarios at 15 years after inoculation, the medical costs and quality of life impact (QALY) for conditions related to the vaccination and disease. The estimated age specific HA incidence rates of the cohorts without vaccination fitted the observed age specific HA incidence rates quite well, indicating the correctness of our calculation models. Under the basecase assumptions, vaccination in general population would entail medical costs. The average CER was 153,277.6 Yuan/QALY, 11 times more than the average per-capita GNP in 1994. The basecase CERs varied from 113,369.3 Yuan/QALY in 10-19 years of age to 292,138.3 Yuan/QALY in age group 50-years. However, much better CERs are found when vaccination is directed toward a high risk population. In this case, widespread use of HAV vaccine in general population with intermediate epidemicity would not be cost-effective while it should be only focused on the high risk population. Sensitivity analysis showed that none of the basic variables might change this conclusion.

Authors+Show Affiliations

Chinese Academy of Preventive Medicine, Beijing.No affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

10322718

Citation

Li, X, et al. "[Epidemiology and Cost-effectiveness Analysis of Hepatitis a Vaccination in Liuzhou City]." Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, vol. 19, no. 2, 1998, pp. 93-6.
Li X, Xu Z, Hofman A. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City]. Zhonghua Liu Xing Bing Xue Za Zhi. 1998;19(2):93-6.
Li, X., Xu, Z., & Hofman, A. (1998). [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, 19(2), 93-6.
Li X, Xu Z, Hofman A. [Epidemiology and Cost-effectiveness Analysis of Hepatitis a Vaccination in Liuzhou City]. Zhonghua Liu Xing Bing Xue Za Zhi. 1998;19(2):93-6. PubMed PMID: 10322718.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City]. AU - Li,X, AU - Xu,Z, AU - Hofman,A, PY - 1999/5/14/pubmed PY - 1999/5/14/medline PY - 1999/5/14/entrez SP - 93 EP - 6 JF - Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi JO - Zhonghua Liu Xing Bing Xue Za Zhi VL - 19 IS - 2 N2 - The changes of annual incidence rates were predicted for 7 cohorts of different ages either with or without vaccination. Cost-effectiveness ratio (CER) was estimated by the annual differences of HA incidence of the two scenarios at 15 years after inoculation, the medical costs and quality of life impact (QALY) for conditions related to the vaccination and disease. The estimated age specific HA incidence rates of the cohorts without vaccination fitted the observed age specific HA incidence rates quite well, indicating the correctness of our calculation models. Under the basecase assumptions, vaccination in general population would entail medical costs. The average CER was 153,277.6 Yuan/QALY, 11 times more than the average per-capita GNP in 1994. The basecase CERs varied from 113,369.3 Yuan/QALY in 10-19 years of age to 292,138.3 Yuan/QALY in age group 50-years. However, much better CERs are found when vaccination is directed toward a high risk population. In this case, widespread use of HAV vaccine in general population with intermediate epidemicity would not be cost-effective while it should be only focused on the high risk population. Sensitivity analysis showed that none of the basic variables might change this conclusion. SN - 0254-6450 UR - https://www.unboundmedicine.com/medline/citation/10322718/[Epidemiology_and_cost_effectiveness_analysis_of_hepatitis_A_vaccination_in_Liuzhou_City]_ L2 - http://www.diseaseinfosearch.org/result/3332 DB - PRIME DP - Unbound Medicine ER -